BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

CELLERANT THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

CELLERANT THERAPEUTICS

via POLICY DIRECTIONS INC.

2nd Quarter (Apr 1 - June 30) · 2010Posted Jul 14, 2010Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: CELLERANT THERAPEUTICS
Description: Research and development of therapeutics
Location: California · United States of America

Registrant

Firm: POLICY DIRECTIONS INC.
Description: Government Relations
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Budget/Appropriations
Increased funding for Biodefense advanced research development through BARDA.
LobbyistsSTEPHEN MICHAEL · FRANKIE L TRULL
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.